• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶C的θ亚型通过调节不同的紧密连接蛋白同种型改变肠上皮屏障功能:一种调节通透性的新机制。

theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability.

作者信息

Banan A, Zhang L J, Shaikh M, Fields J Z, Choudhary S, Forsyth C B, Farhadi A, Keshavarzian A

机构信息

Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, USA.

出版信息

J Pharmacol Exp Ther. 2005 Jun;313(3):962-82. doi: 10.1124/jpet.104.083428.

DOI:10.1124/jpet.104.083428
PMID:15900076
Abstract

Using monolayers of intestinal Caco-2 cells, we discovered that the isoform of protein kinase C (PKC), a member of the "novel" subfamily of PKC isoforms, is required for monolayer barrier function. However, the mechanisms underlying this novel effect remain largely unknown. Here, we sought to determine whether the mechanism by which PKC- disrupts monolayer permeability and dynamics in intestinal epithelium involves PKC--induced alterations in claudin isotypes. We used cell clones that we recently developed, clones that were transfected with varying levels of plasmid to either stably suppress endogenous PKC- activity (antisense, dominant-negative constructs) or to ectopically express PKC- activity (sense constructs). We then determined barrier function, claudin isotype integrity, PKC- subcellular activity, claudin isotype subcellular pools, and claudin phosphorylation. Antisense transfection to underexpress the PKC- led to monolayer instability as shown by reduced 1) endogenous PKC- activity, 2) claudin isotypes in the membrane and cytoskeletal pools ( downward arrowclaud-1, downward arrowclaud-4 assembly), 3) claudin isotype phosphorylation ( downward arrow phospho-serine, downward arrow phospho-threonine), 4) architectural stability of the claudin-1 and claudin-4 rings, and 5) monolayer barrier function. In these antisense clones, PKC- activity was also substantially reduced in the membrane and cytoskeletal cell fractions. In wild-type (WT) cells, PKC- (82 kDa) was both constitutively active and coassociated with claudin-1 (22 kDa) and claudin-4 (25 kDa), forming endogenous PKC-/claudin complexes. In a second series of studies, dominant-negative inhibition of the endogenous PKC- caused similar destabilizing effects on monolayer barrier dynamics, including claudin-1 and -4 hypophosphorylation, disassembly, and architectural instability as well as monolayer disruption. In a third series of studies, sense overexpression of the PKC- caused not only a mostly cytosolic distribution of this isoform (i.e., <12% in the membrane + cytoskeletal fractions, indicating PKC- inactivity) but also led to disruption of claudin assembly and barrier function of the monolayer. The conclusions of this study are that PKC- activity is required for normal claudin assembly and the integrity of the intestinal epithelial barrier. These effects of PKC- are mediated at the molecular level by changes in phosphorylation, membrane assembly, and/or organization of the subunit components of two barrier function proteins: claudin-1 and claudin-4 isotypes. The ability of PKC- to alter the dynamics of permeability protein claudins is a new function not previously ascribed to the novel subfamily of PKC isoforms.

摘要

利用肠道Caco-2细胞单层,我们发现蛋白激酶C(PKC)的一种异构体,即PKC“新”亚家族的成员,是单层屏障功能所必需的。然而,这种新效应背后的机制在很大程度上仍然未知。在这里,我们试图确定PKC-破坏肠道上皮单层通透性和动力学的机制是否涉及PKC-诱导的紧密连接蛋白同种型的改变。我们使用了我们最近开发的细胞克隆,这些克隆用不同水平的质粒转染,以稳定抑制内源性PKC-活性(反义、显性负性构建体)或异位表达PKC-活性(正义构建体)。然后我们测定了屏障功能、紧密连接蛋白同种型完整性、PKC-亚细胞活性、紧密连接蛋白同种型亚细胞池以及紧密连接蛋白磷酸化。反义转染使PKC-表达不足导致单层不稳定,表现为:1)内源性PKC-活性降低;2)膜和细胞骨架池中的紧密连接蛋白同种型减少(紧密连接蛋白-1减少,紧密连接蛋白-4组装减少);3)紧密连接蛋白同种型磷酸化减少(丝氨酸磷酸化减少,苏氨酸磷酸化减少);4)紧密连接蛋白-1和紧密连接蛋白-4环的结构稳定性降低;5)单层屏障功能降低。在这些反义克隆中,膜和细胞骨架细胞组分中的PKC-活性也显著降低。在野生型(WT)细胞中,PKC-(82 kDa)既有组成性活性,又与紧密连接蛋白-1(22 kDa)和紧密连接蛋白-4(25 kDa)共缔合,形成内源性PKC-/紧密连接蛋白复合物。在第二项系列研究中,对内源性PKC-的显性负性抑制对单层屏障动力学产生了类似的破坏作用,包括紧密连接蛋白-1和-4的低磷酸化、解聚、结构不稳定以及单层破坏。在第三项系列研究中,PKC-的正义过表达不仅导致该异构体主要分布在细胞质中(即膜+细胞骨架组分中<12%,表明PKC-无活性),而且还导致紧密连接蛋白组装破坏和单层屏障功能受损。本研究的结论是,PKC-活性是正常紧密连接蛋白组装和肠道上皮屏障完整性所必需的。PKC-的这些作用在分子水平上是通过两种屏障功能蛋白亚基组分的磷酸化、膜组装和/或组织变化介导的:紧密连接蛋白-1和紧密连接蛋白-4同种型。PKC-改变通透性蛋白紧密连接蛋白动力学的能力是PKC异构体新亚家族以前未被归因的新功能。

相似文献

1
theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability.蛋白激酶C的θ亚型通过调节不同的紧密连接蛋白同种型改变肠上皮屏障功能:一种调节通透性的新机制。
J Pharmacol Exp Ther. 2005 Jun;313(3):962-82. doi: 10.1124/jpet.104.083428.
2
Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.蛋白激酶C的ζ亚型可防止氧化剂诱导的核因子-κB激活和I-κBα降解:这是表皮生长因子保护微管细胞骨架和肠屏障完整性的基本机制。
J Pharmacol Exp Ther. 2003 Oct;307(1):53-66. doi: 10.1124/jpet.103.053835. Epub 2003 Jul 31.
3
Critical role of the atypical {lambda} isoform of protein kinase C (PKC-{lambda}) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium.蛋白激酶C非典型λ亚型(PKC-λ)在氧化剂诱导的微管细胞骨架破坏及肠上皮屏障功能中的关键作用
J Pharmacol Exp Ther. 2005 Feb;312(2):458-71. doi: 10.1124/jpet.104.074591. Epub 2004 Sep 3.
4
Theta-isoform of PKC is required for alterations in cytoskeletal dynamics and barrier permeability in intestinal epithelium: a novel function for PKC-theta.蛋白激酶C的θ亚型是肠道上皮细胞骨架动力学和屏障通透性改变所必需的:蛋白激酶C-θ的新功能。
Am J Physiol Cell Physiol. 2004 Jul;287(1):C218-34. doi: 10.1152/ajpcell.00575.2003. Epub 2004 Feb 25.
5
Inhibition of oxidant-induced nuclear factor-kappaB activation and inhibitory-kappaBalpha degradation and instability of F-actin cytoskeletal dynamics and barrier function by epidermal growth factor: key role of phospholipase-gamma isoform.表皮生长因子对氧化剂诱导的核因子-κB激活、抑制性κBα降解以及F-肌动蛋白细胞骨架动力学和屏障功能不稳定性的抑制作用:磷脂酶γ亚型的关键作用
J Pharmacol Exp Ther. 2004 Apr;309(1):356-68. doi: 10.1124/jpet.103.062232. Epub 2004 Jan 14.
6
The delta-isoform of protein kinase C causes inducible nitric-oxide synthase and nitric oxide up-regulation: key mechanism for oxidant-induced carbonylation, nitration, and disassembly of the microtubule cytoskeleton and hyperpermeability of barrier of intestinal epithelia.蛋白激酶C的δ亚型可导致诱导型一氧化氮合酶和一氧化氮上调:这是氧化剂诱导的微管细胞骨架羰基化、硝化、解聚以及肠上皮屏障通透性增加的关键机制。
J Pharmacol Exp Ther. 2003 May;305(2):482-94. doi: 10.1124/jpet.102.047308. Epub 2003 Feb 11.
7
PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury.蛋白激酶C-ζ是表皮生长因子保护微管及肠道屏障完整性免受氧化损伤所必需的。
Am J Physiol Gastrointest Liver Physiol. 2002 May;282(5):G794-808. doi: 10.1152/ajpgi.00284.2001.
8
Investigation into the signal transduction pathway via which heat stress impairs intestinal epithelial barrier function.热应激损害肠道上皮屏障功能的信号转导途径研究。
J Gastroenterol Hepatol. 2007 Nov;22(11):1823-31. doi: 10.1111/j.1440-1746.2006.04710.x.
9
Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.通过抑制丝氨酸蛋白酶消除干扰素-γ介导的上皮屏障破坏。
Clin Exp Immunol. 2005 Nov;142(2):275-84. doi: 10.1111/j.1365-2249.2005.02906.x.
10
Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation.蛋白激酶C通过转录调控增强原代培养的人鼻上皮细胞的紧密连接屏障功能。
Mol Pharmacol. 2008 Aug;74(2):432-42. doi: 10.1124/mol.107.043711. Epub 2008 May 13.

引用本文的文献

1
MUC13 negatively regulates tight junction proteins and intestinal epithelial barrier integrity via protein kinase C.MUC13 通过蛋白激酶 C 负调控紧密连接蛋白和肠道上皮屏障完整性。
J Cell Sci. 2024 Mar 1;137(5). doi: 10.1242/jcs.261468. Epub 2024 Mar 13.
2
Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut.非消化性低聚糖对肠漏的直接作用。
Nutrients. 2022 Nov 7;14(21):4699. doi: 10.3390/nu14214699.
3
Effects of daidzein on antioxidant capacity in weaned pigs and IPEC-J2 cells.大豆苷元对断奶仔猪和IPEC-J2细胞抗氧化能力的影响。
Anim Nutr. 2022 Jul 14;11:48-59. doi: 10.1016/j.aninu.2022.06.014. eCollection 2022 Dec.
4
Impairment of the Retinal Endothelial Cell Barrier Induced by Long-Term Treatment with VEGF-A No Longer Depends on the Growth Factor's Presence.长期使用 VEGF-A 治疗会损害视网膜内皮细胞屏障,而这种损害不再依赖于生长因子的存在。
Biomolecules. 2022 May 23;12(5):734. doi: 10.3390/biom12050734.
5
Artificial Sweeteners Disrupt Tight Junctions and Barrier Function in the Intestinal Epithelium through Activation of the Sweet Taste Receptor, T1R3.人工甜味剂通过激活甜味受体 T1R3 破坏肠道上皮细胞的紧密连接和屏障功能。
Nutrients. 2020 Jun 22;12(6):1862. doi: 10.3390/nu12061862.
6
Role of Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.肠毒素在伴异型增生的结直肠无蒂锯齿状腺瘤/息肉中对 YAP 激活的作用。
Int J Mol Sci. 2020 May 28;21(11):3840. doi: 10.3390/ijms21113840.
7
Transport Mechanisms of Polymannuronic Acid and Polyguluronic Acid Across Caco-2 Cell Monolayers.聚甘露糖醛酸和聚古罗糖醛酸跨Caco-2细胞单层的转运机制
Pharmaceutics. 2020 Feb 17;12(2):167. doi: 10.3390/pharmaceutics12020167.
8
ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells.ADAM15 介导 Claudin-1 在乳腺癌细胞中的表达上调。
Sci Rep. 2019 Aug 29;9(1):12540. doi: 10.1038/s41598-019-49021-3.
9
Claudin 1 Is Highly Upregulated by PKC in MCF7 Human Breast Cancer Cells and Correlates Positively with PKCε in Patient Biopsies.紧密连接蛋白1在MCF7人乳腺癌细胞中被蛋白激酶C高度上调,且在患者活检中与蛋白激酶Cε呈正相关。
Transl Oncol. 2019 Mar;12(3):561-575. doi: 10.1016/j.tranon.2018.12.011. Epub 2019 Jan 15.
10
Dietary Fiber Treatment Corrects the Composition of Gut Microbiota, Promotes SCFA Production, and Suppresses Colon Carcinogenesis.膳食纤维治疗可纠正肠道微生物群组成,促进短链脂肪酸生成,并抑制结肠癌发生。
Genes (Basel). 2018 Feb 16;9(2):102. doi: 10.3390/genes9020102.